Indoco Remedies Limited (NSE:INDOCO)
226.00
+3.32 (1.49%)
Aug 21, 2026, 3:29 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 20.89 billion as of August 21, 2026. Its market cap has decreased by -20.02% in one year.
Market Cap
20.89B
Enterprise Value
31.38B
Revenue
18.73B
Ranking
n/a
PE Ratio
371.00
Stock Price
226.00
ChartMarket Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 20.89B, an increase of 348.22%. That is a compound annual growth rate of 7.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 20.89B | -3.48% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 62.67B |
| Innova Captab | 62.04B |
| Orchid Pharma | 49.68B |
| RPG Life Sciences | 44.12B |
| Ind-Swift Laboratories | 28.01B |
| Solara Active Pharma Sciences | 26.50B |
| Beta Drugs | 24.22B |
| Windlas Biotech | 19.91B |